Articles

PP03 Amsacrine combined with high dose cytarabine in relapsed/refractory acute myeloid leukemia (rraml)

BJH - 2018, issue Abstract Book BHS, february 2018

A. Salaroli MD, D. Bron MD, PhD, M. Paesmans , B. Cantinieaux , P. Heimann MD, PhD, P. Lewalle MD, PhD, S. Wittnebel MD, PhD

Read more

P31 Approach of an IgM monoclonal gammopathy: clinical relevance of the MYD88 L265P mutation

BJH - 2018, issue Abstract Book BHS, february 2018

M. Vercruyssen MD, N. Cilla , L. Ameye , M. Paesmans , A. De Wind MD, PhD, P. Heimann MD, PhD, N. Meuleman MD, PhD, D. Bron MD, PhD

Read more

P.36 Management of fit older AML: major prognostic value of cytogenetic markers is confirmed whatever the age

BJH - 2013, issue BHS Abstractbook, january 2013

J. Nguyen , B. Bailly MD, P. Sidon , J. Hotton , M. Roos , M. Maerevoet MD, P. Lewalle MD, PhD, N. Meuleman MD, PhD, M. Paesmans , D. Bron MD, PhD

Read more